MDGL

Madrigal Pharmaceuticals, Inc.

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$546.89

Market Cap

$12.55B

Beta

-0.96

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+432.05%

EPS Growth (YoY)+41.79%

Revenue CAGR 3Y+0.00%

P/E Ratio0.0

PEG Ratio—

FCF Yield-1.51%

Debt / Equity0.59

Interest Coverage-13.5x

No credit card required

Already have an account? Sign in to view the full analysis for MDGL.